NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,015 | -8.5% | 163,792 | +19.6% | 1.12% | +1.5% |
Q2 2023 | $2,202 | -7.7% | 136,973 | 0.0% | 1.11% | -9.0% |
Q1 2023 | $2,385 | +143.4% | 136,973 | +29.2% | 1.22% | +129.4% |
Q4 2022 | $980 | -99.9% | 105,997 | 0.0% | 0.53% | 0.0% |
Q3 2022 | $913,000 | +3.4% | 105,997 | -2.1% | 0.53% | +6.4% |
Q2 2022 | $883,000 | -32.7% | 108,272 | +0.2% | 0.50% | -17.5% |
Q1 2022 | $1,313,000 | -63.7% | 108,054 | 0.0% | 0.60% | -57.9% |
Q4 2021 | $3,617,000 | -30.6% | 108,054 | 0.0% | 1.44% | -20.6% |
Q3 2021 | $5,212,000 | +6.2% | 108,054 | -0.6% | 1.81% | +9.3% |
Q2 2021 | $4,909,000 | -6.3% | 108,672 | 0.0% | 1.65% | -15.6% |
Q1 2021 | $5,241,000 | -10.4% | 108,672 | 0.0% | 1.96% | -10.2% |
Q4 2020 | $5,851,000 | +43.8% | 108,672 | -1.4% | 2.18% | +17.8% |
Q3 2020 | $4,068,000 | +18.9% | 110,265 | -0.1% | 1.85% | +1.5% |
Q2 2020 | $3,420,000 | +43.3% | 110,385 | +27.7% | 1.83% | -35.8% |
Q1 2020 | $2,386,000 | -41.3% | 86,410 | -37.8% | 2.84% | -27.6% |
Q4 2019 | $4,062,000 | – | 138,855 | – | 3.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |